Barış EMEKDAŞ, Ayfer HAYDAROĞLU, Erhan GÖKMEN, Fatma SERT, Pınar GÜRSOY, Burcu ÇAKAR, Zeynep ÖZSARAN

Long-Term Follow-Up of Patients with Male Breast Cancer, Single-Center Experience

OBJECTIVEMale breast cancer (BC) represents

PDF

___

1. Korde LA, Zujewski JA, Kamin L, Giordano S, Domchek S, Anderson WF et al. Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol 2010;28(12):2114–22.
2. Leon-Ferre RA, Giridhar KV, Hieken TJ, Mutter RW, Couch FJ, Jimenez RE et al. A contemporary review of male breast cancer: current evidence and unanswered questions. Cancer Metastasis Rev 2018;37(4):599–614.
3. Gucalp A, Traina TA, Eisner JR, Parker JS, Selitsky SR, Park BH et al. Male breast cancer: a disease distinct from female breast cancer. Breast Cancer Res Treat 2019;173(1):37–48.
4. Sánchez-Muñoz A, Vicioso L, Santonja A, Álvarez M, Plata-Fernández Y, Miramón J et al. Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes. Mod Pathol 2018;31(2):299–306.
5. Bloom KJ, Govil H, Gattuso P, Reddy V, Francescatti D. Status of HER-2 in male and female breast carcinoma. Am J Surg 2001;182(4):389–92.
6. Curigliano G, Colleoni M, Renne G, Mazzarol G, Gennari R, Peruzzotti G et al. Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assay. Ann Oncol 2002;13(6):895–902.
7. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012;490(7418):61–70.
8. Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015;26 Suppl 5:v8–30.
9. Ma CX, Ellis MJ. The Cancer Genome Atlas: clinical applications for breast cancer. Oncology (Williston Park) 2013;27(12):1263-9, 1274–9.
10.Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA et al. Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. Clin Cancer Res 2015;21(7):1688–98.
11.Piscuoglio S, Ng CK, Murray MP, Guerini-Rocco E, Martelotto LG, Geyer FC et al. The Genomic Landscape of Male Breast Cancers. Clin Cancer Res 2016;22(16):4045–56.
12.Mazouni C, Rimareix F, Mathieu MC, Uzan C, Bourgier C, André F et al. Outcome in breast molecular subtypes according to nodal status and surgical procedures. Am J Surg 2013;205(6):662–7.
13.Vermeulen MA, Slaets L, Cardoso F, Giordano SH, Tryfonidis K, van Diest PJ et al. Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Eur J Cancer 2017;82:219–227.